286 related articles for article (PubMed ID: 30554198)
1. Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy.
Brand FL; Seyed Jafari SM; Hunger RE
Dermatology; 2019; 235(2):150-155. PubMed ID: 30554198
[TBL] [Abstract][Full Text] [Related]
2. In vivo reflectance confocal microscopy to monitor the response of lentigo maligna to imiquimod.
Alarcon I; Carrera C; Alos L; Palou J; Malvehy J; Puig S
J Am Acad Dermatol; 2014 Jul; 71(1):49-55. PubMed ID: 24725478
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors.
Guitera P; Haydu LE; Menzies SW; Scolyer RA; Hong A; Fogarty GB; Gallardo F; Segura S
Br J Dermatol; 2014 Jun; 170(6):1305-12. PubMed ID: 24641247
[TBL] [Abstract][Full Text] [Related]
4. Reflectance confocal microscopy and its role in the follow-up of a topical treatment for lentigo maligna.
Coco V; Perino F; Di Stefani A; Cappilli S; Peris K
Int J Dermatol; 2021 Feb; 60(2):196-200. PubMed ID: 32710558
[TBL] [Abstract][Full Text] [Related]
5. The smart approach: feasibility of lentigo maligna superficial margin assessment with hand-held reflectance confocal microscopy technology.
Pellacani G; De Carvalho N; Ciardo S; Ferrari B; Cesinaro AM; Farnetani F; Bassoli S; Guitera P; Star P; Rawson R; Rossi E; Magnoni C; Gualdi G; Longo C; Scope A
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1687-1694. PubMed ID: 29704275
[TBL] [Abstract][Full Text] [Related]
6. Topical 5% imiquimod in the treatment of lentigo maligna.
Wong JG; Toole JW; Demers AA; Musto G; Wiseman MC
J Cutan Med Surg; 2012; 16(4):245-9. PubMed ID: 22784516
[TBL] [Abstract][Full Text] [Related]
7. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
Costa MC; Abraham LS; Barcaui C
An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lentigo maligna with imiquimod 5% cream.
Hopson B; Richey D; Sajben FP
J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
[TBL] [Abstract][Full Text] [Related]
9. Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy.
Guitera P; Moloney FJ; Menzies SW; Stretch JR; Quinn MJ; Hong A; Fogarty G; Scolyer RA
JAMA Dermatol; 2013 Jun; 149(6):692-8. PubMed ID: 23553208
[TBL] [Abstract][Full Text] [Related]
10. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
Bartenjev MS; Isaković-Vidović S; Bartenjev I
Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
[TBL] [Abstract][Full Text] [Related]
11. Videodermatoscopy of lentigo maligna treated with imiquimod.
Micali G; Lacarrubba F; Nardone B; Nasca MR
J Drugs Dermatol; 2008 Nov; 7(11):1077-80. PubMed ID: 19110742
[TBL] [Abstract][Full Text] [Related]
12. Dermoscopy vs. reflectance confocal microscopy for the diagnosis of lentigo maligna.
Cinotti E; Labeille B; Debarbieux S; Carrera C; Lacarrubba F; Witkowski AM; Moscarella E; Arzberger E; Kittler H; Bahadoran P; Gonzalez S; Guitera P; Agozzino M; Farnetani F; Hofmann-Wellenhof R; Ardigò M; Rubegni P; Tognetti L; Łudzik J; Zalaudek I; Argenziano G; Longo C; Ribero S; Malvehy J; Pellacani G; Cambazard F; Perrot JL
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1284-1291. PubMed ID: 29341263
[TBL] [Abstract][Full Text] [Related]
13. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
14. Ingenol Mebutate for Lentigo Maligna: A Case Report.
Gadaldi K; Feldmeyer L; Yawalkar N; Hunger RE
Dermatology; 2016; 232 Suppl 1():24-8. PubMed ID: 27513527
[TBL] [Abstract][Full Text] [Related]
15. Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.
Soenen A; Vourc'h M; Khammari A; Nguyen JM; Bossard C; Denis Musquer M; Vergier B; Dréno B
J Am Acad Dermatol; 2022 May; 86(5):1042-1048. PubMed ID: 33785385
[TBL] [Abstract][Full Text] [Related]
16. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
[TBL] [Abstract][Full Text] [Related]
17. Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
Kai AC; Richards T; Coleman A; Mallipeddi R; Barlow R; Craythorne EE
Br J Dermatol; 2016 Jan; 174(1):165-8. PubMed ID: 26595446
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
[TBL] [Abstract][Full Text] [Related]
19. Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
Navarrete-Dechent C; Cordova M; Aleissa S; Liopyris K; Dusza SW; Kose K; Busam KJ; Hollman T; Lezcano C; Pulitzer M; Chen CJ; Lee EH; Rossi AM; Nehal KS
J Am Acad Dermatol; 2023 Feb; 88(2):371-379. PubMed ID: 31812621
[TBL] [Abstract][Full Text] [Related]
20. Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study.
Gautschi M; Oberholzer PA; Baumgartner M; Gadaldi K; Yawalkar N; Hunger RE
J Am Acad Dermatol; 2016 Jan; 74(1):81-87.e1. PubMed ID: 26601565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
